APA (7th ed.) Citation

Dama, P., Frampton, A. E., Pickford, E., Tookman, L., Cunnea, P., Fotopoulou, C., . . . Krell, J. (2023). Immune modulation and the oral live biotherapeutic product, MRx0518, in treatment-naïve patients with cancer: Updated safety data. Journal of clinical oncology, 41(16_suppl), 3145. https://doi.org/10.1200/JCO.2023.41.16_suppl.3145

Chicago Style (17th ed.) Citation

Dama, Paola, et al. "Immune Modulation and the Oral Live Biotherapeutic Product, MRx0518, in Treatment-naïve Patients with Cancer: Updated Safety Data." Journal of Clinical Oncology 41, no. 16_suppl (2023): 3145. https://doi.org/10.1200/JCO.2023.41.16_suppl.3145.

MLA (9th ed.) Citation

Dama, Paola, et al. "Immune Modulation and the Oral Live Biotherapeutic Product, MRx0518, in Treatment-naïve Patients with Cancer: Updated Safety Data." Journal of Clinical Oncology, vol. 41, no. 16_suppl, 2023, p. 3145, https://doi.org/10.1200/JCO.2023.41.16_suppl.3145.